43 related articles for article (PubMed ID: 9174050)
1. Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development.
Iwamoto M; Higuchi Y; Koyama E; Enomoto-Iwamoto M; Kurisu K; Yeh H; Abrams WR; Rosenbloom J; Pacifici M
J Cell Biol; 2000 Jul; 150(1):27-40. PubMed ID: 10893254
[TBL] [Abstract][Full Text] [Related]
2. Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines.
Nhili R; Peixoto P; Depauw S; Flajollet S; Dezitter X; Munde MM; Ismail MA; Kumar A; Farahat AA; Stephens CE; Duterque-Coquillaud M; David Wilson W; Boykin DW; David-Cordonnier MH
Nucleic Acids Res; 2013 Jan; 41(1):125-38. PubMed ID: 23093599
[TBL] [Abstract][Full Text] [Related]
3. Open chromatin profiling identifies AP1 as a transcriptional regulator in oesophageal adenocarcinoma.
Britton E; Rogerson C; Mehta S; Li Y; Li X; ; Fitzgerald RC; Ang YS; Sharrocks AD
PLoS Genet; 2017 Aug; 13(8):e1006879. PubMed ID: 28859074
[TBL] [Abstract][Full Text] [Related]
4. Association of Long Non-Coding RNAs (lncRNAs)
Yao Y; Liang Y; Dong X; Liu S; Zhang S; Liu W; Li Y; Shi L; Yan Z; Yao Y
Pharmgenomics Pers Med; 2022; 15():359-375. PubMed ID: 35480403
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
Łukasik P; Załuski M; Gutowska I
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805800
[TBL] [Abstract][Full Text] [Related]
6. EGR1 promotes stemness and predicts a poor outcome of uterine cervical cancer by inducing SOX9 expression.
Zhao J; Li H; Yuan M
Genes Genomics; 2021 May; 43(5):459-470. PubMed ID: 33687657
[TBL] [Abstract][Full Text] [Related]
7. Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro.
Li Q; Yang L; Han K; Zhu L; Zhang Y; Ma S; Zhang K; Yang B; Guan F
Oncotarget; 2016 Sep; 7(38):61458-61468. PubMed ID: 27556183
[TBL] [Abstract][Full Text] [Related]
8. An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer.
Lorenzo E; Camacho-Caceres K; Ropelewski AJ; Rosas J; Ortiz-Mojer M; Perez-Marty L; Irizarry J; Gonzalez V; Rodríguez JA; Cabrera-Rios M; Isaza C
Microarrays (Basel); 2015 Jun; 4(2):287-310. PubMed ID: 26388997
[TBL] [Abstract][Full Text] [Related]
9. Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.
Marques RB; Dits NF; Erkens-Schulze S; van Ijcken WF; van Weerden WM; Jenster G
PLoS One; 2011; 6(8):e23144. PubMed ID: 21829708
[TBL] [Abstract][Full Text] [Related]
10. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.
Miettinen M; Wang ZF; Paetau A; Tan SH; Dobi A; Srivastava S; Sesterhenn I
Am J Surg Pathol; 2011 Mar; 35(3):432-41. PubMed ID: 21317715
[TBL] [Abstract][Full Text] [Related]
11. The function of APC/CCdh1 in cell cycle and beyond.
Li M; Zhang P
Cell Div; 2009 Jan; 4():2. PubMed ID: 19152694
[TBL] [Abstract][Full Text] [Related]
12. The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.
Davidson B; Goldberg I; Tell L; Vigdorchik S; Baekelandt M; Berner A; Kristensen GB; Reich R; Kopolovic J
Clin Exp Metastasis; 2004; 21(3):191-9. PubMed ID: 15387369
[TBL] [Abstract][Full Text] [Related]
13. erg, an ets-related gene, codes for sequence-specific transcriptional activators.
Reddy ES; Rao VN
Oncogene; 1991 Dec; 6(12):2285-9. PubMed ID: 1766675
[TBL] [Abstract][Full Text] [Related]
14. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
[TBL] [Abstract][Full Text] [Related]
15. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of the ets genes and their products.
Watson DK; Ascione R; Papas TS
Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
[TBL] [Abstract][Full Text] [Related]
17. Ets factors and regulation of the extracellular matrix.
Trojanowska M
Oncogene; 2000 Dec; 19(55):6464-71. PubMed ID: 11175362
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.
Simpson S; Woodworth CD; DiPaolo JA
Oncogene; 1997 May; 14(18):2149-57. PubMed ID: 9174050
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
